A boxed warning for testosterone on major adverse cardiovascular events is out and a new blood pressure warning is in, the ...

Testosterone replacement therapy, which involves taking manufactured forms of testosterone, has surged in popularity. ...

The FDA has recommended several labeling changes to all approved testosterone replacement therapy products based on the ...

Hall scheduled an appointment with a specialist, and in 2024 started testosterone replacement therapy (TRT)—receiving regular ...

The TRAVERSE trial, a large-scale clinical study with over 5,000 patients, published in 2023, concluded that TRT does not increase the risk of adverse cardiovascular outcomes in men with hypogonadism.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Medical experts reveal the often-missed signals of testosterone deficiency in men, from subtle mood changes to unexplained ...

The FDA has announced new labeling changes for all testosterone products following a review of clinical trial data, including a TRAVERSE study and postmarket ambulatory blood pressure studies.

Whether you played a sport in high school, college or even at the professional level, chances are you heard someone in a ...

Hypogonadism is a syndrome that affects both males and females. It’s associated with hormone deficiencies in the gonads ...